טוען...
Downregulation of microRNA-132 indicates progression in hepatocellular carcinoma
Although miR-132 has been studied in various human tumors, few studies have investigated the role of miR-132 in hepatocellular carcinoma (HCC). The present study aimed to evaluate the associations between miR-132 and clinicopathological parameters, including recurrence, in patients with HCC. Reverse...
שמור ב:
| הוצא לאור ב: | Exp Ther Med |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
D.A. Spandidos
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5038555/ https://ncbi.nlm.nih.gov/pubmed/27698698 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2016.3613 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|